Local versus central laboratory discrepancies in the determination of triple-negative breast cancer (TNBC) status in a large phase III (CIBOMA/2004-01/GEICAM/2003−11) trial assessing adjuvant capecitabine (C) maintenance therapy after standard chemotherapy (CT) in early breast cancer (EBC) patients (pts).
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. Ruiz-Borrego, C. H. Barrios, A. Lluch, J. Bines, J. G. M. Segalla, A. Ruiz, L. Torrecillas, A. Llombart-Cussac, R. Torres, J. Á. Garcia Saenz, J. A. Lopez Garcia-Asenjo, H. L. Gomez, J. R. De la Haba, S. Reyes, E. Martinez, J. M. Baena, L. Perez-Michell, A. Rodriguez-Lescure, A. Anton, M. Martin, On behalf of CIBOMA/GEICAM
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2591241748